SynthesisEndocrine2020
The efficacy and safety of combinations of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes or obese adults: a systematic review and meta-analysis.
Man Guo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled ittrialcites it